Dengue fever risk Dengue PRNT Neutralizing antibody Seroprevalence Seroepidemiology Serological study Bangkok adults healthcare workers Thailand
Conditions
Interventions
Sponsors
Sanofi Pasteur, Thailand
Queen Sirikit National Institute of Child Health
Eligibility
Sex/Gender
All
Age
21 Years to 60 Years
Inclusion criteria
Inclusion criteria: Medical personnel who underwent a medical examination in the year 2015 at Queen Sirikit National Institute of Child Health, and voluntarily join the study
Exclusion criteria
Exclusion criteria: Who did not provided informed consent to a blood test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proportion of protective DF antibody Upon enrollment Plaque reduction neutralization test for Dengue fever | — |
Secondary
| Measure | Time frame |
|---|---|
| Predictors of protective antibibody Upon enrollment age, residencial area | — |
Countries
Thailand
Contacts
Public ContactWarunee Vandepitte
QSNICH
Outcome results
None listed